logo-loader
LSE:MXC OTC:MGCLF ASX:MXC

MGC Pharmaceuticals Ltd

Receive alerts
Market:
LSE
Price
21.10 GBX
Day Change
0.48%
Market Cap:
£9.25 m
52 weeks high
600.00
52 weeks low
13.10

In brief

MGC Pharmaceuticals Ltd is a European based pharmaceutical company, focused on developing and supplying accessible and ethically produced plant inspired medicines, combining in-house research with innovative technologies, with the goal of finding or producing treatments to for unmet medical conditions.

The company's founders and executives are key figures in the global pharmaceuticals industry and the core business strategy is to develop and supply high quality plant inspired medicines for the growing demand in the medical markets in Europe, North America and Australasia.

MGC Pharma has a robust development pipeline targeting two widespread medical conditions and has further products under development. 

Snapshot

  • MGC Pharma reports progress 'across all fronts'
  • MGC Pharmaceuticals: plant-based treatment to address unmet medical needs
  • MGC Pharmaceuticals’ first steps in the US market ‘a large opportunity,’ broker says
  • MGC Pharmaceuticals reveals strategic objectives for H1 2024